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egetation Size
arker for Extraction Technique?*
ames D. Maloney, MD,†
ames D. Maloney III, MD‡
verland Park, Kansas; and Madison, Wisconsin
he descriptive analysis in this issue of the Journal by
rammes et al. (1) of their percutaneous rhythm device-
ead extraction experience in 100 infective endocarditis
atients with 216 leads (average lead age 4 years) and further
omplicated by large intracardiac vegetations is admirable,
nstructive, and thought provoking. The data primarily
ome from prospectively maintained lead extraction records,
lus retrospective assessment of the pre- and post-extraction
ourse during a 16-year time frame.
See page 886
All 100 patients and their infected leads were complicated
y intra-cardiac vegetations ranging in size from 0.2 to 4.0
m (mean 1.6 cm), all fulfilling the modified Duke criteria
2) for possible or definite rhythm device-related infective
ndocarditis. The principle management team included the
acemaker electrophysiology extraction members, anesthe-
iologists, and infectious disease consultants, and cardiac
urgeons only when new epicardial lead systems were
equired in 2 patients. Throughout the 16 years of this
etrospective analysis, a generally consistent therapeutic
pproach was followed by this center that included local and
ertiary referral patients. The authors’ lead extraction ap-
roach included the following: 1) attempted identification
f the infecting organism with cultures; 2) pre-procedure
sophageal echo imaging (transesophageal echocardiogra-
hy) for identification of vegetations from in-house or
eferral sources, plus localizing and sizing of right-sided
eart vegetations; 3) infectious disease service management
f antibiotics to suppress bacteremia; 4) extraction of all
mplanted pulse generators and intravascular leads using
ercutaneous extraction tools and techniques of the day,
egardless of vegetation size or location; 5) post-lead extrac-
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
From the †Cardiovascular Services, Heartland Spine and Specialty Hospital,
verland Park, Kansas; and the ‡Department of Cardiothoracic Surgery, Universitys
f Wisconsin, and Section of Thoracic Surgery, William S. Middleton Memorial VA
ospital, Madison, Wisconsin.ion/transvenous pacing, antibiotics, medical treatment of
rogressive heart failure and overwhelming sepsis, plus
ubsequent reimplantation of new, usually transvenous,
mplanted pulse generator–lead systems when appropriate.
The authors noted that extraction times were equal to (or
horter for infected leads) lead extraction times for 2,004
oninfected leads. We believe this is a valid observation, but
arely documented in print or timed, and is assumed to be due
o localized bacterial breakdown of fibrosis and tissue adjacent
o the lead, and not necessarily related to vegetation.
Size of the vegetations did not alter the authors’ pre-
rocedure evaluation, extraction techniques, and timing, nor
id they find that vegetations have a significant effect on
cute procedure mortality. Two patients did have acute
ulmonary and hemodynamic symptoms attributed to veg-
tation embolus; both stabilized in a few hours. Hospital
ortality and 30-day mortality totaled 10 patients (10%),
nd no deaths were directly related to a pulmonary vegeta-
ion embolus; however, most deaths were attributed to
rogressive heart failure and overwhelming sepsis. One
atient did have procedure-related severe traumatic tricus-
id insufficiency. Late mortality was 19%, although some
atients were lost to follow-up.
The authors’ procedural success with percutaneous lead
xtraction for patients with infective endocarditis (IE) and
arge vegetations is encouraging and adds significantly to
xisting reports advocating percutaneous removal (3–6).
hese data support the growing belief that right-sided heart
egetations 3 or 4 cm (or regardless of size) are not a
ontraindication to percutaneous lead extraction. However,
here are dissenters, especially from the cardiac surgical
ommunity, who vigorously contend that rhythm device-
elated IE with large vegetations should be managed with
urgical removal including debridement despite significant
orbidity and mortality. Unfortunately, randomized trials
o not exist regarding this issue and are unlikely to be
erformed any time in the near future. Our review of the IE
iterature identifies left-sided heart vegetation as a major
isk marker, and subsequent embolization as a life-
hreatening event complicating 20% to 50% of left-sided
eart IE cases (7–9). This is particularly true when vegeta-
ions are 10 mm and have increasing proclivity to embo-
ize. Current literature review suggests the 3 major indica-
ions for surgical management of left-sided IE are: 1) new
nset or progressive heart failure; 2) uncontrolled infection;
nd 3) prevention of embolic vegetation (9,10). Rarely do
egetations exist alone. Left-sided surgical intervention is
irected toward removing the vegetations, while also cor-
ecting for causes of congestive heart failure (valve repair),
long with debriding and draining infectious sources that
re resistant to antibiotic penetration (11). Isolated surgical
emoval of left heart vegetation does not reduce mortality
11–13).
It seems that criteria for left-sided heart IE and direct





































































































896 Maloney and Maloney III JACC Vol. 55, No. 9, 2010
Vegetation Size as Marker for Extraction Technique March 2, 2010:895–7ide heart vegetations without considering all of the nu-
nces. Most of these patients are very sick: right- or
eft-sided heart IE complicated by large vegetations. All
ould agree that right-sided heart IE with large vegetations
s not good, but the data of Grammes et al. (1), and those
f others (3,4,10), suggest that even large embolic right-
ided heart vegetations can be withstood by most patients if
oexisting endocarditis is suppressed and eventually cured in
he setting of successful total device and lead extraction. The
rammes data also identify a number of patients with
uccessfully extracted hardware and large vegetations who
rogressed to a state of intractable congestive heart failure
nd/or uncontrolled and overwhelming sepsis despite ap-
ropriate medical treatment. Apparently, the vegetations of
hese patients disappeared with extraction, but the remain-
ng right-sided heart environment is unknown. Mortality from
ncontrolled sepsis, with and without heart failure despite
ppropriate antibiotics, could, in part, be due to residual
nfected inflammatory tissue, possibly within the right heart,
ung, or implant pocket, or related to the temporary pacing
eads, even with prior total hardware extraction (14–17). If we
gree that extensive debridement of pectoral pockets and aortic
erivalvular abscesses is important, then the potential value of
ight-sided heart debridement in refractory rhythm device IE
after lead removal), should be further considered, studied, and
efined.
A simple investigative approach would be to perform
utopsies on patients with device-related endocarditis who
uccumbed to uncontrolled sepsis despite total transvenous
ardware extraction. A residual abscessed tissue-scar com-
lex that promotes embolized vegetation is also possibly
eeding the rest of the body and contributing to refractori-
ess of infection and congestive failure. Another investiga-
ional tool is delayed-enhancement magnetic resonance
maging (18,19) of post-extraction patients with continued
epsis in an attempt to identify specific sites of right-sided
eart inflammatory tissue impervious to antibiotic therapy.
f found, imaging could guide surgeons or electrophysiolo-
ists toward targeted intracardiac debridement.
Grammes et al. (1) are to be congratulated for their acutely
uccessful transvenous lead extraction experience in the
resence of large right-sided heart vegetations. The results,
oth short and long term, can help formulate additional
uestions and treatment strategies to deal with the presence
r absence of possible residual inflammatory tissue with and
ithout vegetations. Grammes et al. (1) demonstrate that
ercutaneous lead extraction with vegetations of all sizes is
ossible and seemingly appropriate. Techniques to collect or
uction the vegetation before embolizing could be devel-
ped, and may be helpful. The question remains, however,
f a nidus of chronic infection sometimes remains, does that
ause refractory sepsis and congestive heart failure? Can and
hould it be removed surgically?
Although not directly related to intracardiac vegetations, the
uestion of silent bacterial spread of device-pocket infection to
he heart needs more investigation. Is it possible that the openumen of the typical lead permits bacteria to hide from
ntibiotics within the fluid-filled connecter block? Then can it
ilently travel to the endocardial tip to repetitively initiate
ursts of bacteremia and endocarditis, thereby enabling drain-
ge from a relatively normal looking pectoral pocket? Would a
ead without a lumen help solve this problem? Is this a
roblem? A team approach of device-extraction specialists
long with infectious disease physicians, cardiac surgeons,
maging experts, pathologists, device manufacturers, and others
ay best solve these clinical puzzles. Similarly, once endocar-
itis becomes refractory to medical therapy despite percutane-
us hardware extraction, can directed surgical intervention
mprove patient outcomes?
As one glances back to the time of emerging open heart
urgery, iatrogenic heart block, and the first battery-powered
acemakers, specialists of every type came together as one large
ommunity to solve common problems. Today, we are build-
ng compartmentalized units of medicine, or “silos” (20), that
re becoming smaller and smaller. The upward thrust of the
ilo is often impressive and rapid, but isolated. For example,
ardiac electrophysiology is a silo of subspecialty practice
erived in part from cardiology, internal medicine, and surgery.
ardiac electrophysiology is now making smaller silos consist-
ng of noninvasive, invasive, and interventional physicians, plus
eart failure specialists implanting biventricular devices, inter-
entional atrial fibrillation ablation specialists, ventricular
achycardia ablation specialists, device follow-up specialists,
ead extraction specialists, and others. The unintended conse-
uences of too narrow a focus, or too small a silo, may delay
nd geographically or departmentally disperse care, and that
ould end up being counter to a patient-centered health care
elivery system.
It seems that in future investigations of this type, the
haping, evaluating, and drawing of meaningful conclusions
ight benefit from the knowledge and experience of mul-
iple specialties, both medical and surgical. The broader
erspective rather than a narrow silo framework may result
n more clinically significant observations. In the present
tudy, IE and its sequelae, vegetations, generate other
nanswered questions: Why do some patients get better
ith extractions and others do not? Are vegetations and
egetation size only markers of underlying infection?
There appears to be a need to explore these questions
hrough a broader framework for more comprehensive
nderstanding. The excellent work by Grammes et al. (1)
eeds to be continued.
eprint requests and correspondence: Dr. James D. Maloney,
arondelet Heart Institute, Cardiology, 1000 Carondelet Drive,
ansas City, Missouri 64114. E-mail: jdmepmd@aol.com.
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